Oxidative Stress in Neurodegenerative Diseases

Area of Science:

• Neuroscience
• Pathophysiology
• Pharmacology

Background:

• Neurodegenerative diseases, including Alzheimer's (AD), Parkinson's (PD), and amyotrophic lateral sclerosis (ALS), have complex and incompletely understood pathophysiologies.
• Oxidative stress (OS) is increasingly implicated as a significant factor in the pathogenesis of these disorders.
• Elevated OS biomarkers and reduced antioxidant defenses are observed in affected tissues.

Purpose of the Study:

• To review the role of OS in neurodegenerative disease pathogenesis.
• To analyze drug-induced modulation of oxidative balance.
• To explore pharmacotherapeutic strategies targeting OS reduction.

Main Methods:

• Review of clinical trials and animal studies on OS in neurodegeneration.
• Analysis of pharmacological interventions affecting oxidative balance.
• Exploration of therapeutic approaches for OS modulation.

Main Results:

• Evidence links higher OS biomarkers to neurodegenerative conditions.
• Lower antioxidant defense biomarkers are associated with these diseases.
• Drug-induced modulation of oxidative balance is a key area of investigation.

Conclusions:

• OS plays a critical role in the development of neurodegenerative diseases.
• Targeting OS pharmacologically presents a promising therapeutic avenue.
• Further research into OS reduction strategies is warranted for AD, PD, and ALS.